DOSING GUIDE

Retatrutide 8mg

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, making it the most aggressive weight loss peptide in late-stage clinical development. It outperforms semaglutide and tirzepatide in trial data, with Phase 3 showing up to 24% body weight reduction — the highest of any injectable peptide to date.

TYPICAL DOSE

1 mg / week

INJECTION

Subcutaneous

HALF-LIFE

~6 days

STORAGE

2 – 8 °C

Usage guide & Dosage

Syringe units assume a 8mg vial mixed with 2ml of bacteriostatic water (4mg/ml)

Dose per injection, frequency, and total weekly amount across experience levels.

1 mg

per injection

DRAW VOLUME

0.25 ml

25 units

FREQUENCY

1x / week

CYCLE LENGTH

4 weeks

then up dosage

1 mg / week

4 mg

per injection

DRAW VOLUME

1 ml

100 units

FREQUENCY

1x / week

CYCLE LENGTH

4 - 12 weeks

then up dosage

4 mg / week

8 mg

per injection

DRAW VOLUME

2 ml

200 units

FREQUENCY

1x / week

CYCLE LENGTH

Continuous

maintenance phase

8 mg / week

Tips & Notes

Timing

Once weekly subcutaneous injection, same day each week — consistency matters more than time of day. Dosing in the evening can help sleep through the worst of early nausea.

Cycling

No defined cycle length — designed as a long-term chronic therapy like semaglutide. Discontinuation typically results in weight regain, so stopping should be intentional and paired with a maintenance strategy.

Stacking

Avoid stacking with other GLP-1 agonists — redundant and compounds GI side effects badly. Pairs well with HHB for micronutrient support since appetite suppression at this level can create deficiencies.

Storage

Lyophilized: fridge for regular use, freezer for long-term. Reconstituted: fridge only, use within 4 weeks, never freeze reconstituted vials, protect from light.

Products listed here are intended for laboratory research and development purposes only. Not for human consumption, medical use, or diagnostic purposes.

Produk-produk yang terdaftar disini hanya untuk keperluan riset dan pengembangan di laboratorium. Tidak untuk konsumsi manusia, penggunaan medis, atau terapi.